BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Sep. 2, 2009
View Archived Issues
Strong Data Have Nitec Eying 2010 Filing in RA for Lodotra
Nitec Pharma AG has obtained positive data from a second Phase III trial of Lodotra in rheumatoid arthritis (RA), paving the way for a U.S. regulatory filing next year. (BioWorld International)
Read More
$210M Deal Gives Endo Rights to Testosterone Gel Fortesta
Read More
Bug Contributes to Cancer: May Be 'H. Pylori of Colon Cancer'
Read More
Silence Remaining Silent on Size of Research Deal
Read More
Mondobiotech Shares on the Rise After Cashless Listing
Read More
Ark Testing Second-Generation Gene Therapy in Heart Ailment
Read More
UK Losing Leading Stem Cell Scientist: Minger Joins GE Firm
Read More
Other News To Note
Read More